AtriCure's sales grew 15% last quarter to $154.5 million, with a profit of $4.1 million.

ATRC · AtriCure, Inc.

The AI's read

Higher adjusted operating profit and a wider gross margin show that growth reached beyond sales alone. The company also expects $606 million to $610 million in sales for 2026, though the source gives no earlier estimate for comparison. Falling minimally invasive ablation sales are a concern, but growth in three named devices and stronger overall measures carry more weight.